“To earn the trust of the medical fraternity and patients through concern, care and cure”.
…Bridge the gap against resistance
  • Zyphar’s 2nd company to launch Tigecycline-the first clinically available glycylcycline to help tackle ESBLs & MDR

  • Complicated Skin & Soft Tissue Infections
  • Complicated Intra Abdominal Infections
  • Community Acquired Pneumonia

  • 100mg loading, then 50mg q 12h
  • Infusion rate- 30-60 minutes

  • 53mg/vial+5.3ml normal saline
  • 5ml of above solution + 100ml IV fluid/li>

Copyrights @ 2012 : Zyphar's Pharmaceutics